NITI Aayog Ayurveda Roadmap for Global Ayurveda by 2047

Why in News?

NITI Aayog released the report “Strategic Roadmap for Making Ayurveda Global” on 2 July 2026.The report presents a detailed assessment of Ayurveda’s global presence and proposes a phased strategy up to 2047, aligned with the vision of Viksit Bharat@2047.The roadmap aims to strengthen India’s position as a global leader in traditional medicine by improving research, education, exports, regulation, branding and international partnerships.

What is Ayurveda?

• Ayurveda is one of India’s oldest systems of medicine and forms an important part of the broader AYUSH framework.
• It focuses on preventive care, balanced living, personalised treatment and the use of natural substances. Its classical knowledge base is linked with texts such as Charaka Samhita and Sushruta Samhita, which deal with medicine, diagnosis, surgery and therapeutics.

Ayurveda’s strength lies in its emphasis on:

• Prevention of disease
• Personalised healthcare
• Diet and lifestyle regulation
• Natural and plant-based therapies
• Long-term wellness and rehabilitation

This preventive and holistic orientation makes Ayurveda relevant at a time when the world is facing rising lifestyle diseases, chronic disorders and mental-health concerns.

AYUSH Systems

India’s traditional healthcare landscape includes multiple recognised systems under AYUSH:

Ayurveda:

• A classical Indian system focused on balance, prevention, treatment and healthy living.

Yoga and Naturopathy:

• Yoga emphasises physical, mental and spiritual discipline, while naturopathy relies on natural healing through diet, lifestyle and elements of nature.

Unani:

• A traditional system influenced by Greco-Arab medical thought and later developed in India.

Siddha:

• A traditional medical system associated mainly with southern India, especially Tamil traditions.

Sowa-Rigpa:

• A Himalayan medical tradition practised in regions such as Ladakh and parts of the Himalayan belt.

Homoeopathy:

• A system based on principles such as minimum dose and “like cures like”, introduced into India during the colonial period.
• Among these, Ayurveda has strong potential for global expansion because of its association with wellness, preventive healthcare and India’s civilisational knowledge traditions.

Current Global Status of Ayurveda

Ayurveda’s international footprint has expanded, but its global presence remains uneven.

Rising exports:

• The export value of Ayurveda and herbal products increased from about USD 1.09 billion in 2014 to nearly USD 2.16 billion in 2023, reaching around 150 countries.

Partial global recognition:

• Ayurveda is formally recognised in nearly 30 countries, though recognition varies across licensing, practice and academic models.

Strong domestic workforce:

• India has more than 3.55 lakh trained Ayurveda practitioners, but nearly 95% of them are based within India. This indicates limited global mobility of qualified professionals.

International research presence:

• Ayurveda-related research now spans nearly 70 countries, supported by academic collaborations and institutional partnerships.

WHO-linked progress:

• The WHO Global Traditional Medicine Centre at Jamnagar, Gujarat, has strengthened India’s position in global traditional-medicine discourse.

Global classification support:

• Ayurveda, Siddha and Unani have been integrated into the WHO International Classification of Diseases-11 through the Traditional Medicine module. WHO’s coding of traditional-medicine interventions under ICHI can support tracking, billing, research and policy recognition.

Academic outreach:

• Ayush Chairs in institutions such as the University of Mauritius and Western Sydney University support international teaching and research, though a globally standardised curriculum is still needed.

NITI Aayog’s Three-Pillar Framework

The report uses a three-pillar framework for globalising Ayurveda: Availability, Acceptability and Propagation.

1. Availability

This pillar focuses on making Ayurveda accessible globally through trained professionals, quality products, research and education.

It includes:

• Global practice and workforce expansion
• International exports and manufacturing
• Research and development partnerships
• Standardised global education and training

Availability is essential because Ayurveda cannot become global without qualified practitioners, reliable products and credible institutions.

2. Acceptability

This pillar deals with trust, regulation and institutional recognition.

It includes:

• Compliance with global regulations
• International academic and industry collaborations
• Insurance coverage
• Cultural adaptation and localisation

Acceptability is crucial because global health systems require evidence, safety, quality assurance and clear regulatory pathways.

3. Propagation

This pillar focuses on communication and global visibility.

It includes:

• Strategic brand positioning
• International promotion
• Medical value travel
• Representation in global bodies

Propagation can help Ayurveda move from a niche wellness identity to a recognised healthcare and wellness system.

Strategic Roadmap up to 2047

Short Term: Foundation Building up to 2029

The immediate phase focuses on institutions, information and quality systems.

Key priorities include:

Mission Steering Group:

• A high-level Mission Steering Group chaired by the Minister of Ayush can coordinate research, diplomacy, trade and education.

Global Ayurveda Register:

• A digital credentialing and continuous professional development system can help identify qualified practitioners worldwide.

Global Information Portal:

• A single-window platform can provide country-wise information on licensing, visas, compliance and practice requirements.

Manufacturing certification:

• Fast-tracking WHO-GMP-equivalent certification for major manufacturers can improve product credibility.

Export-focused pharmacopoeia:

• An export edition of the Ayurvedic Pharmacopoeia can standardise sourcing, quality and contaminant profiling.

Trade dashboard:

• A real-time Ayurveda trade dashboard and better HS-code alignment can support exports and trade negotiations.

Medium Term: Market Integration up to 2035

The second phase aims to integrate Ayurveda with international markets and institutions.

Key priorities include:

Product registration:

• Selected formulations can be registered under international frameworks such as the European Union’s Traditional Herbal Medicinal Products Directive.

Insurance pilots:

• Ayurveda coverage can be piloted in select OECD countries for defined conditions.

Mutual Recognition Arrangements:

• Professional mobility can be supported through agreements with partner countries and blocs such as G20, BRICS and ASEAN.

International education:

Ayurveda electives, micro-credentials and Ayush Chair-linked courses can be introduced in foreign medical institutions.

Medical Value Travel hubs:

International Ayurveda hubs can combine treatment, diagnostics, Ayush Visa services and tele-consultation follow-up.

Multi-country trials:

Clinical research across countries can build stronger evidence and improve international acceptance.

Traditional Knowledge Digital Library:

Modernising TKDL can protect India’s intellectual property and prevent misappropriation of traditional knowledge.

Long Term: Systemic Integration up to 2047

The long-term goal is to make Ayurveda a trusted and regulated component of global healthcare.

The roadmap aims for:

• Formal recognition or integration of Ayurveda in at least 20 national health systems
• Insurance coverage for defined Ayurveda indications in at least 10 countries
• A global network of International Ayurveda Centres of Excellence
• Stronger evidence systems, quality labs, education platforms and public outcome dashboards
• A credible global brand narrative for Ayurveda

The focus is not only on exports but also on responsible integration into healthcare systems.

SWOT Analysis of Ayurveda’s Globalisation

Strengths

Holistic health orientation:

Ayurveda’s focus on prevention, lifestyle and wellness matches global demand for holistic healthcare.

Personalised care:

Its Prakriti-based approach offers individualised treatment possibilities.

Civilisational credibility:

Ayurveda benefits from India’s long traditional knowledge base and the global popularity of Yoga.

Scope for integration:

It can complement modern medicine in chronic disease management, rehabilitation and preventive care.

Weaknesses

Regulatory gaps:

Many countries do not recognise Ayurveda as a formal medical system.

Limited practitioner mobility:

Qualified practitioners are heavily concentrated in India.

Evidence challenges:

Personalised treatment models make conventional randomised trials difficult.

Quality concerns:

Inconsistent manufacturing practices, contamination concerns and high compliance costs affect credibility.

Insurance limitations:

Ayurveda has limited insurance coverage outside India.

Opportunities

Global wellness market:

Rising demand for preventive healthcare, nutraceuticals and functional foods creates new opportunities.

Medical Value Travel:

India can attract international patients seeking integrated wellness and traditional healthcare.

International collaborations:

Ayush Chairs, scholarships and research partnerships can strengthen knowledge networks.

WHO-linked recognition:

ICD-11 and ICHI coding can support global documentation, research and policy adoption.

Ayush Visa:

Dedicated visa support can make India a more attractive destination for traditional medical care.

Threats

Global competition:

Traditional Chinese Medicine has expanded rapidly with strong state support, standards and overseas centres.

Weak coordination:

Fragmented efforts among researchers, industry, regulators and practitioners may slow progress.

Product classification limits:

Many Ayurvedic products are exported as dietary supplements rather than regulated medicines, limiting clinical value.

Risk of dilution:

Commercial expansion must not weaken Ayurveda’s classical principles or scientific credibility.

Ayurveda and Traditional Chinese Medicine:

• Traditional Chinese Medicine has achieved deeper global integration in several areas, including overseas centres, practitioner licensing, insurance coverage and international standards.
• Ayurveda has made progress through the WHO Global Traditional Medicine Centre, Ayush Information Cells, academic collaborations and exports. However, it still needs stronger global practitioner networks, dedicated international standards, broader insurance coverage and recognised pathways for clinical practice.
• This comparison shows that Ayurveda’s globalisation requires not only cultural promotion but also regulation, evidence, education and market strategy.

Significance for India

Health diplomacy:

• Ayurveda can strengthen India’s international engagement under the idea of One Earth, One Health.

Economic value:

• Exports, wellness tourism, manufacturing and research services can generate income and employment.

Soft power:

• Ayurveda, along with Yoga, can deepen India’s cultural influence.

Medical Value Travel:

• India can position itself as a destination for integrated and preventive healthcare.

Traditional knowledge protection:

• Strengthened documentation can protect indigenous knowledge from misuse.

Viksit Bharat@2047:

• A globally recognised Ayurveda ecosystem can support India’s aspirations in health, economy and knowledge leadership.

Key Challenges

• Lack of uniform international regulation
• Limited global recognition as a medical system
• Shortage of certified practitioners abroad
• Absence of standardised international curricula
• Need for stronger clinical evidence
• Quality-control concerns in products

Way Forward

• Establish internationally credible Ayurveda education standards.
• Expand global certification and credentialing of practitioners.
• Strengthen clinical trials for defined conditions.
• Ensure strict product quality, safety and contaminant testing.
• Promote WHO-GMP-equivalent manufacturing.

Conclusion

NITI Aayog’s roadmap marks an important step in transforming Ayurveda from a largely India-centred traditional system into a regulated, evidence-supported and globally trusted healthcare option.

The opportunity is significant: Ayurveda can strengthen India’s health diplomacy, exports, medical value travel and cultural soft power. But global acceptance will depend on quality, safety, evidence, regulation and professional standards.

By combining ancient knowledge with modern validation and global partnerships, India can make Ayurveda a credible pillar of global well-being by 2047.